C11742_CD Unlvr_NNP AR_NNP eng_FW 154-164_CD ._.
qxd_NN 8_CD 3_CD 05_CD 11:22_CD PM_NNP Page_NNP 159_CD Additional_JJ information_NN for_IN US_NNP investors_NNS continued_VBD Unilever_NNP Group_NNP Long_NNP leasehold_VBD interests_NNS in_IN land_NN Under_IN UK_NNP GAAP_NNP ,_, Unilever_NNP treats_VBZ the_DT cost_NN of_IN acquiring_VBG a_DT long_JJ leasehold_NN interest_NN in_IN land_NN as_IN a_DT xed_JJ asset_NN ,_, and_CC depreciates_VBZ the_DT cost_NN of_IN that_DT asset_NN over_IN the_DT lease_NN term_NN ._.
Under_IN US_NNP GAAP_NNP ,_, the_DT cost_NN of_IN long_JJ leasehold_NN interests_NNS would_MD be_VB deferred_VBN within_IN Other_JJ assets_NNS and_CC recognized_VBN on_IN a_DT straightline_JJ basis_NN over_IN the_DT lives_NNS of_IN the_DT leases_NNS as_IN operating_VBG lease_NN rentals_NNS ._.
The_DT balance_NN of_IN such_JJ assets_NNS were_VBD 43_CD million_CD as_IN at_IN 31_CD December_NNP 2004_CD 2003_CD :_: 58_CD million_CD ._.
In_IN all_DT other_JJ respects_NNS ,_, there_EX are_VBP no_DT differences_NNS in_IN accounting_NN for_IN these_DT arrangements_NNS between_IN UK_NNP and_CC US_NNP GAAP_NNP ._.
Equity_NN in_IN earnings_NNS related_VBN to_TO investments_NNS in_IN joint_JJ ventures_NNS and_CC associated_VBN companies_NNS Under_IN US_NNP GAAP_NNP ,_, equity_NN in_IN earnings_NNS related_VBN to_TO investments_NNS in_IN joint_JJ ventures_NNS and_CC associated_VBN companies_NNS would_MD be_VB disclosed_VBN on_IN a_DT single_JJ line_NN within_IN the_DT income_NN statement_NN ._.
In_IN particular_JJ ,_, our_PRP$ share_NN of_IN the_DT interest_NN and_CC taxation_NN arising_VBG in_IN respect_NN of_IN joint_JJ ventures_NNS and_CC associated_VBN companies_NNS would_MD be_VB reported_VBN on_IN this_DT line_NN ,_, rather_RB than_IN as_IN part_NN of_IN the_DT total_JJ interest_NN and_CC taxation_NN charge_NN for_IN the_DT Group_NNP ._.
US_NNP GAAP_NNP equity_NN in_IN earnings_NNS related_VBN to_TO investments_NNS in_IN joint_JJ ventures_NNS and_CC associated_VBN companies_NNS were_VBD 57_CD million_CD for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD 2003_CD :_: 48_CD million_CD :_: 2002_CD :_: 54_CD million_CD ._.
Recently_RB issued_VBN accounting_NN pronouncements_NNS In_IN January_NNP 2003_CD ,_, the_DT FASB_NNP issued_VBD Financial_NNP Interpretation_NNP No._NN ._.
46_CD FIN_NNP 46_CD ,_, Consolidation_NN of_IN Variable_JJ Interest_NN Entities_NNS and_CC in_IN December_NNP 2003_CD issued_VBD a_DT revised_VBN interpretation_NN FIN_NNP 46_CD R._NNP Under_IN these_DT interpretations_NNS ,_, certain_JJ entities_NNS known_VBN as_IN variable_JJ interest_NN entities_NNS must_MD be_VB consolidated_VBN by_IN the_DT primary_JJ beneciary_NN of_IN the_DT entity_NN ._.
During_IN 2004_CD ,_, Unilever_NNP reviewed_VBD its_PRP$ contractual_JJ arrangements_NNS with_IN potential_JJ variable_JJ interest_NN entities_NNS and_CC identied_VBD certain_JJ arrangements_NNS that_WDT qualify_VBP as_IN variable_JJ interest_NN entities_NNS under_IN FIN_NNP 46_CD R._NNP These_DT variable_JJ interest_NN entities_NNS relate_VBP to_TO certain_JJ leasing_NN ,_, manufacturing_NN and_CC distribution_NN agreements_NNS ._.
Unilever_NNP is_VBZ not_RB the_DT primary_JJ beneciary_NN of_IN any_DT of_IN these_DT entities_NNS ._.
The_DT total_JJ maximum_JJ loss_NN exposure_NN relating_VBG to_TO these_DT entities_NNS is_VBZ not_RB material_NN ._.
In_IN December_NNP 2003_CD ,_, the_DT Medicare_NNP Prescription_NNP Drug_NNP Improvement_NNP and_CC Modernization_NNP Act_NNP of_IN 2003_CD the_DT Medicare_NNP Act_NNP became_VBD law_NN in_IN the_DT United_NNP States_NNPS ._.
The_DT Medicare_NNP Act_NNP provides_VBZ for_IN two_CD new_JJ prescription_NN drug_NN benefit_NN features_NNS under_IN Medicare_NNP ._.
Unilever_NNP provides_VBZ post-retirement_JJ healthcare_NN benets_NNS to_TO its_PRP$ United_NNP States_NNPS employees_NNS so_IN the_DT benets_NNS provided_VBN are_VBP impacted_VBN by_IN the_DT Medicare_NNP Act_NNP ._.
In_IN May_NNP 2004_CD ,_, the_DT FASB_NNP issued_VBD FSP_NNP 106-2_CD ,_, Accounting_NNP and_CC Disclosure_NNP Modernization_NNP Act_NNP of_IN 2003_CD to_TO provide_VB guidance_NN on_IN accounting_NN for_IN the_DT effects_NNS of_IN the_DT Medicare_NNP Act_NNP ._.
FSP_NNP 106-2_CD is_VBZ effective_JJ for_IN Unilevers_NNP 2004_CD financial_JJ statements_NNS ._.
The_DT expected_VBN subsidy_NN reduced_VBN Unilevers_NNP accumulated_VBN benefit_NN obligation_NN by_IN approximately_RB 52_CD million_CD ,_, which_WDT Unilever_NNP recognized_VBD in_IN the_DT statement_NN of_IN total_JJ recognized_VBN gains_NNS and_CC losses_NNS ._.
The_DT impact_NN on_IN the_DT ongoing_JJ service_NN cost_NN is_VBZ a_DT reduction_NN by_IN an_DT immaterial_JJ amount_NN ._.
In_IN December_NNP 2004_CD ,_, the_DT FASB_NNP issued_VBD FASB_NNP Statement_NNP No._NN ._.
123_CD Revised_VBN ,_, Share-Based_NNP Payments_NNS which_WDT provides_VBZ guidance_NN on_IN how_WRB companies_NNS must_MD measure_VB compensation_NN cost_NN relating_VBG to_TO share-based_JJ payment_NN transactions_NNS in_IN their_PRP$ financial_JJ statements_NNS ._.
123_CD Revised_VBN is_VBZ effective_JJ for_IN Unilevers_NNP 2005_CD financial_JJ statements_NNS ._.
123_CD Revised_VBN is_VBZ not_RB expected_VBN to_TO have_VB a_DT significant_JJ impact_NN on_IN the_DT consolidated_JJ results_NNS of_IN operations_NNS or_CC financial_JJ position_NN of_IN Unilever_NNP as_IN Unilever_NNP adopted_VBD the_DT fair_JJ value_NN measurement_NN provisions_NNS of_IN FASB_NNP Statement_NNP No._NN ._.
In_IN November_NNP 2004_CD ,_, the_DT FASB_NNP issued_VBD FASB_NNP Statement_NNP No._NN ._.
151_CD ,_, Inventory_NNP Costs_NNS an_DT amendment_NN of_IN ARB_NNP 43_CD to_TO clarify_VB the_DT existing_VBG requirements_NNS in_IN ARB_NNP No._NN ._.
43_CD by_IN adopting_VBG language_NN similar_JJ to_TO that_DT used_VBN in_IN IAS_NNP 2_CD ._.
The_DT guidance_NN is_VBZ effective_JJ for_IN inventory_NN costs_NNS incurred_VBN during_IN scal_JJ years_NNS beginning_VBG after_IN 15_CD June_NNP 2003_CD ._.
FAS_NNP 151_CD does_VBZ not_RB have_VB an_DT impact_NN on_IN the_DT results_NNS of_IN operations_NNS or_CC financial_JJ position_NN of_IN Unilever_NNP since_IN the_DT key_JJ elements_NNS are_VBP already_RB applied_VBN in_IN Unilevers_NNP financial_JJ statements_NNS ._.
In_IN March_NNP 2004_CD ,_, the_DT EITF_NNP reached_VBD consensus_NN on_IN Issue_NNP No._NN ._.
03-01_CD ,_, The_DT Meaning_NNP of_IN Other-Than-Temporary_NNP Impairment_NNP and_CC its_PRP$ Application_NN to_TO Certain_NNP Investments_NNP EITF_NNP 03-01_CD ._.
EITF_NNP 03-01_CD provides_VBZ guidance_NN on_IN other-than-temporary_JJ impairment_NN models_NNS for_IN marketable_JJ debt_NN and_CC equity_NN securities_NNS and_CC non-marketable_JJ securities_NNS accounted_VBD for_IN under_IN the_DT cost_NN method_NN ._.
In_IN September_NNP 2004_CD ,_, the_DT FASB_NNP delayed_VBD the_DT effective_JJ date_NN for_IN the_DT recognition_NN and_CC measurement_NN guidance_NN in_IN EITF_NNP 03-01_CD ,_, until_IN certain_JJ implementation_NN issues_NNS are_VBP addressed_VBN ._.
The_DT disclosure_NN requirements_NNS in_IN EITF_NNP 03-01_CD remain_VBP effective_JJ ._.
When_WRB issued_VBN ,_, EITF_NNP 03-01_CD is_VBZ not_RB expected_VBN to_TO have_VB a_DT material_NN impact_NN on_IN Unilevers_NNP financial_JJ position_NN or_CC results_NNS of_IN operations_NNS ._.
Documents_NNS on_IN display_NN in_IN the_DT United_NNP States_NNPS Unilever_NNP les_FW and_CC furnishes_VBZ reports_NNS and_CC information_NN with_IN the_DT United_NNP States_NNP Securities_NNPS and_CC Exchange_NNP Commission_NNP SEC_NNP ,_, and_CC such_JJ reports_NNS and_CC information_NN can_MD be_VB inspected_VBN and_CC copied_VBN at_IN the_DT SECs_NNS public_JJ reference_NN facilities_NNS in_IN Washington_NNP DC_NNP ,_, Chicago_NNP and_CC New_NNP York_NNP ._.
Certain_NNP of_IN our_PRP$ reports_NNS and_CC other_JJ information_NN that_IN we_PRP le_FW or_CC furnish_VB to_TO the_DT SEC_NNP are_VBP also_RB available_JJ to_TO the_DT public_NN over_IN the_DT internet_NN on_IN the_DT SECs_NNS website_VBP at_IN www_NN ._.
Unilever_NNP Annual_JJ Report_NNP and_CC Accounts_NNPS 2004_CD 159_CD
